The percentage of long-stay residents who are receiving antipsychotic drugs in the target period

Number of Residents Who Received an Antipsychotic Medication

Number of long-stay residents

Residents with Schizophrenia, Tourette's syndrome, Huntington's disease

None

Data collected as part of Minimum Data Set (MDS) which is the federally mandated process for clinical assessment of all residents in Medicare and Medicaid certified nursing homes. This process provides a comprehensive assessment of each resident's functional capabilities and helps nursing home staff identify health problems. MDS assessments are completed for all residents in certified nursing homes, regardless of source of payment for the individual resident. MDS assessments are required for residents on admission to the nursing facility, periodically, and on discharge. All assessments are completed within specific guidelines and time-frames. In most cases, participants in the assessment process are licensed health care professionals employed by the nursing home. MDS information is transmitted electronically by nursing homes to the national MDS database at CMS.

Online at Medicare's compare sites, www.medicare.gov/care-compare/?providerType=NursingHome,

www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/nursinghomequalityinits/nhqiqualitymeasures Gerlach, L. B., Fashaw, S., Strominger, J., Ogarek, J., Zullo, A. R., Daiello, L. A., . . . Bynum, J. P. W. (2021). Trends in antipsychotic prescribing among long-term care residents receiving hospice care. Journal of the American Geriatrics Society, 69(8), 2152-2162.